255 related articles for article (PubMed ID: 35892930)
1. Closing the Door with CRISPR: Genome Editing of CCR5 and CXCR4 as a Potential Curative Solution for HIV.
Freen-van Heeren JJ
BioTech (Basel); 2022 Jul; 11(3):. PubMed ID: 35892930
[TBL] [Abstract][Full Text] [Related]
2. Genome editing of the HIV co-receptors CCR5 and CXCR4 by CRISPR-Cas9 protects CD4
Liu Z; Chen S; Jin X; Wang Q; Yang K; Li C; Xiao Q; Hou P; Liu S; Wu S; Hou W; Xiong Y; Kong C; Zhao X; Wu L; Li C; Sun G; Guo D
Cell Biosci; 2017; 7():47. PubMed ID: 28904745
[TBL] [Abstract][Full Text] [Related]
3. Simultaneous Knockout of CXCR4 and CCR5 Genes in CD4+ T Cells via CRISPR/Cas9 Confers Resistance to Both X4- and R5-Tropic Human Immunodeficiency Virus Type 1 Infection.
Yu S; Yao Y; Xiao H; Li J; Liu Q; Yang Y; Adah D; Lu J; Zhao S; Qin L; Chen X
Hum Gene Ther; 2018 Jan; 29(1):51-67. PubMed ID: 28599597
[TBL] [Abstract][Full Text] [Related]
4. Killing two birds with one stone: CRISPR/Cas9 CCR5 knockout hematopoietic stem cells transplantation to treat patients with HIV infection and hematological malignancies concurrently.
Au TY; Arudkumar J; Assavarittirong C; Benjamin S
Clin Exp Med; 2023 Dec; 23(8):4163-4175. PubMed ID: 37500934
[TBL] [Abstract][Full Text] [Related]
5. Gene Editing of HIV-1 Co-receptors to Prevent and/or Cure Virus Infection.
Allen AG; Chung CH; Atkins A; Dampier W; Khalili K; Nonnemacher MR; Wigdahl B
Front Microbiol; 2018; 9():2940. PubMed ID: 30619107
[TBL] [Abstract][Full Text] [Related]
6. CRISPR-Edited Stem Cells in a Patient with HIV and Acute Lymphocytic Leukemia.
Xu L; Wang J; Liu Y; Xie L; Su B; Mou D; Wang L; Liu T; Wang X; Zhang B; Zhao L; Hu L; Ning H; Zhang Y; Deng K; Liu L; Lu X; Zhang T; Xu J; Li C; Wu H; Deng H; Chen H
N Engl J Med; 2019 Sep; 381(13):1240-1247. PubMed ID: 31509667
[TBL] [Abstract][Full Text] [Related]
7. CRISPR-Cas9-mediated gene disruption of HIV-1 co-receptors confers broad resistance to infection in human T cells and humanized mice.
Li S; Holguin L; Burnett JC
Mol Ther Methods Clin Dev; 2022 Mar; 24():321-331. PubMed ID: 35229006
[TBL] [Abstract][Full Text] [Related]
8. Combination gene therapy for HIV using a conditional suicidal gene with CCR5 knockout.
Mehmetoglu-Gurbuz T; Yeh R; Garg H; Joshi A
Virol J; 2021 Jan; 18(1):31. PubMed ID: 33516234
[TBL] [Abstract][Full Text] [Related]
9. CCR5 Disruption in Induced Pluripotent Stem Cells Using CRISPR/Cas9 Provides Selective Resistance of Immune Cells to CCR5-tropic HIV-1 Virus.
Kang H; Minder P; Park MA; Mesquitta WT; Torbett BE; Slukvin II
Mol Ther Nucleic Acids; 2015 Dec; 4():e268. PubMed ID: 26670276
[TBL] [Abstract][Full Text] [Related]
10.
Xu M
Cell Biosci; 2020; 10():48. PubMed ID: 32257106
[TBL] [Abstract][Full Text] [Related]
11. Comparison of the editing patterns and editing efficiencies of TALEN and CRISPR-Cas9 when targeting the human CCR5 gene.
Nerys-Junior A; Braga-Dias LP; Pezzuto P; Cotta-de-Almeida V; Tanuri A
Genet Mol Biol; 2018; 41(1):167-179. PubMed ID: 29583154
[TBL] [Abstract][Full Text] [Related]
12. Gene Therapy with CRISPR/Cas9 Coming to Age for HIV Cure.
Soriano V
AIDS Rev; 2017; 19(3):167-172. PubMed ID: 29019352
[TBL] [Abstract][Full Text] [Related]
13. CCR5Δ32 mutation and HIV infection: basis for curative HIV therapy.
Allers K; Schneider T
Curr Opin Virol; 2015 Oct; 14():24-9. PubMed ID: 26143158
[TBL] [Abstract][Full Text] [Related]
14. Antiretrovirals to CCR5 CRISPR/Cas9 gene editing - A paradigm shift chasing an HIV cure.
Khan A; Paneerselvam N; Lawson BR
Clin Immunol; 2023 Oct; 255():109741. PubMed ID: 37611838
[TBL] [Abstract][Full Text] [Related]
15. Genome editing of CCR5 by AsCpf1 renders CD4
Liu Z; Liang J; Chen S; Wang K; Liu X; Liu B; Xia Y; Guo M; Zhang X; Sun G; Tian G
Cell Biosci; 2020; 10():85. PubMed ID: 32670545
[TBL] [Abstract][Full Text] [Related]
16. Genome modification of CXCR4 by Staphylococcus aureus Cas9 renders cells resistance to HIV-1 infection.
Wang Q; Chen S; Xiao Q; Liu Z; Liu S; Hou P; Zhou L; Hou W; Ho W; Li C; Wu L; Guo D
Retrovirology; 2017 Nov; 14(1):51. PubMed ID: 29141633
[TBL] [Abstract][Full Text] [Related]
17. Editing CCR5: a novel approach to HIV gene therapy.
Cornu TI; Mussolino C; Bloom K; Cathomen T
Adv Exp Med Biol; 2015; 848():117-30. PubMed ID: 25757618
[TBL] [Abstract][Full Text] [Related]
18. CCR5 Targeted Cell Therapy for HIV and Prevention of Viral Escape.
Hütter G; Bodor J; Ledger S; Boyd M; Millington M; Tsie M; Symonds G
Viruses; 2015 Jul; 7(8):4186-203. PubMed ID: 26225991
[TBL] [Abstract][Full Text] [Related]
19. [Application progress of CRISPR/Cas9 genome editing technology in the treatment of HIV-1 infection].
Han Y; Li QW
Yi Chuan; 2016 Jan; 38(1):9-16. PubMed ID: 26787519
[TBL] [Abstract][Full Text] [Related]
20. [Deep lung--cellular reaction to HIV].
Tavares Marques MA; Alves V; Duque V; Botelho MF
Rev Port Pneumol; 2007; 13(2):175-212. PubMed ID: 17492233
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
